The histone deacetylase inhibitor entinostat enhances the efficacy of the MEK inhibitor pimasertib against aggressive types of breast cancer through Noxa-mediated myeloid cell leukemia 1 degradation

被引：0
|
作者：
Torres-Adorno, A. M.
Lee, J. J.
Kogawa, T.
Bartholomeusz, C.
Pitner, M. K.
Ordentlich, P.
Lim, B.
Tripathy, D.
Ueno, N. T.
机构：
[1] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Sect Translat Breast Canc Res, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA
[3] Syndax Pharmaceut Inc, Waltham, MA USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-04-02
引用
下载
收藏
页数：2
相关论文
共 13 条
  • [1] Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer
    Torres-Adorno, Angie M.
    Lee, Jangsoon
    Kogawa, Takahiro
    Ordentlich, Peter
    Tripathy, Debu
    Lim, Bora
    Ueno, Naoto T.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4780 - 4792
  • [2] The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines
    Elmer, Jacob J.
    Christensen, Matthew D.
    Barua, Sutapa
    Lehrman, Jennifer
    Haynes, Karmella A.
    Rege, Kaushal
    BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (06) : 1345 - 1356
  • [3] A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
    Jangsoon Lee
    Chandra Bartholomeusz
    Oula Mansour
    Juliane Humphries
    Gabriel N. Hortobagyi
    Peter Ordentlich
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2014, 146 : 259 - 272
  • [4] A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
    Lee, Jangsoon
    Bartholomeusz, Chandra
    Mansour, Oula
    Humphries, Juliane
    Hortobagyi, Gabriel N.
    Ordentlich, Peter
    Ueno, Naoto T.
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (02) : 259 - 272
  • [5] A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in both HER2-overexpressing inflammatory and non-inflammatory breast cancer cells through FOXO3-mediated Bim1 expression
    Lee, Jangsoon
    Bartholomeusz, Chandra
    Hortobagyi, Gabriel N.
    Ordentlich, Peter
    Ueno, Naoto T.
    CANCER RESEARCH, 2015, 75
  • [6] A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer
    Wu, Yuan-Hua
    Hong, Chi-Wei
    Wang, Yi-Ching
    Huang, Wei-Jan
    Yeh, Ya-Ling
    Wang, Bour-Jr
    Wang, Ying-Jan
    Chiu, Hui-Wen
    CANCER LETTERS, 2017, 400 : 79 - 88
  • [7] Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein
    Zhou, Wenjing
    Zhu, Weiwei
    Ma, Liya
    Xiao, Feng
    Qian, Wenbin
    Oncology Letters, 2015, 10 (05) : 2899 - 2904
  • [8] Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated antitumor efficacy in primary HCC cancer in vitro and in vivo
    Shao, Huanjie
    Tang, Haikuo
    Gao, Chun
    Zhang, Hao
    Dy, Grace
    Yu, Chunrong
    Adjei, Alex
    Roberts, Lewis
    CANCER RESEARCH, 2011, 71
  • [9] A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies
    Huang, Wei-Jan
    Tang, Yen-An
    Chen, Mei-Yu
    Wang, Ying-Jan
    Hu, Fu-Han
    Wang, Tseng-Wei
    Chao, Shi-Wei
    Chiu, Hui-Wen
    Yeh, Ya-Ling
    Chang, Hsin-Yi
    Juan, Hsueh-Fen
    Lin, Pinpin
    Wang, Yi-Ching
    CANCER LETTERS, 2014, 346 (01) : 84 - 93
  • [10] Overcoming MEK inhibitor resistance in triple-negative breast cancer by targeting myeloid cell leukemia-1 (MCL1), an anti-apoptotic protein
    Gagliardi, M.
    Chauhan, G.
    Pitner, M. K.
    Iles, L.
    Qi, Y.
    Pusztai, L.
    Tripathy, D.
    Bartholomeusz, G.
    Bartholomeusz, C.
    CANCER RESEARCH, 2019, 79 (04)
12